Target Poor or Non Binder(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T92777 | Target Info | |||
Target Name | Intestinal maltase-glucoamylase (MGAM) | ||||
Synonyms |
MGAM
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | MGAM | ||||
Biochemical Class | Glycosylase | ||||
UniProt ID |
Poor Binders of This Target (in total, 32 binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
(1R,3S,6R)-6-Hexylamino-4-hydroxymethyl-cyclohex-4-ene-1,2,3-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL354193; BDBM50289175
Click to Show/Hide
|
||||
Activity |
IC50 = 50000 nM
|
[1] | |||
Compound Name |
4-(1,3-Benzothiazol-2-yl)-N-[(E)-(4-hydroxy-3-methoxyphenyl)methylideneamino]benzamide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3407643; BDBM50071934
Click to Show/Hide
|
||||
Activity |
IC50 = 53340 nM
|
[2] | |||
Compound Name |
15-Benzylidene-14-deoxy-11,12-didehydroandrographolide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL238603; BDBM50210445
Click to Show/Hide
|
||||
Activity |
IC50 = 58000 nM
|
[3] | |||
Compound Name |
3-(2-((1R,4As,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decahydronaphthalen-1-yl)vinyl)-5-(3-phenylallylidene)furan-2(5H)-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL209093; BDBM50183257
Click to Show/Hide
|
||||
Activity |
IC50 = 58000 nM
|
[4] | |||
Compound Name |
14-Deoxy-15-(p-(dimethanylamino)-benzylidene)-11,12-didehydroandrographolide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL241165; BDBM50210448
Click to Show/Hide
|
||||
Activity |
IC50 = 70000 nM
|
[3] | |||
Compound Name |
(1S,2S,3R,6S)-6-[[(2S,3R,4S,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL2051979; BDBM50405394
Click to Show/Hide
|
||||
Activity |
IC50 = 80000 nM
|
[5] | |||
Compound Name |
15-(Benzo[1,3]dioxole-5-methanylidene)-14-deoxy-11,12-didehydroandrographolide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL398800; BDBM50210449
Click to Show/Hide
|
||||
Activity |
IC50 = 82000 nM
|
[3] | |||
Compound Name |
14-Deoxy-11,12-didehydro-15-trimethoxylbenzylideneandrographolide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL238604; BDBM50210453
Click to Show/Hide
|
||||
Activity |
IC50 = 84000 nM
|
[3] | |||
Compound Name |
[(2R,3R,4R,5R,6S)-1-[(2R,3R,4R)-3,4-Dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]-2,4,5,6,7-pentahydroxyheptan-3-yl] hydrogen sulfate
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1277152; SCHEMBL12102895
Click to Show/Hide
|
||||
Activity |
Ki = 90000 nM
|
[6] | |||
Compound Name |
(2R,3R,4R,5S)-1-[2,2-Difluoro-5-[(4-phenylphenyl)methoxy]pentyl]-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354620; SCHEMBL17132927; BDBM50028175
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[(4-phenylphenyl)methoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354038; SCHEMBL17132919; BDBM50028218
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[(3-phenylphenyl)methoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354631; SCHEMBL19224268; BDBM50028251
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[(1S)-1-(4-phenylphenyl)ethoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354628; SCHEMBL19224266; BDBM50028248
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[(1R)-1-(4-phenylphenyl)ethoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354629; SCHEMBL19224267; BDBM50028249
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-1-[5-[(2-Fluoro-4-phenylphenyl)methoxy]pentyl]-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354636; SCHEMBL17132918; BDBM50028256
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(S)-3-(2-((4Ar,6aS,7R,10aS,10bR)-3-(3-bromophenyl)-6a,10b-dimethyl-8-methylene-decahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)-4-hydroxy-dihydrofuran-2(3H)-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL379280; BDBM50183253
Click to Show/Hide
|
||||
Activity |
IC50 = 100000 nM
|
[4] | |||
Compound Name |
14-Deoxy-11,12-didehydro-15-(-2-furanmethanylidene)-andrographolide
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL241374; BDBM50210444
Click to Show/Hide
|
||||
Activity |
IC50 = 100000 nM
|
[3] | |||
Compound Name |
(2S,3R,4R,5S)-1-[2,2-Difluoro-5-[(4-phenylphenyl)methoxy]pentyl]-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354632; SCHEMBL19224269; BDBM50028252
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(1S,2S,3R,6S)-6-[[(2R,3R,4S,5R,6S)-4,5-Dihydroxy-6-methoxy-2-methyloxan-3-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL2051764; BDBM50405386
Click to Show/Hide
|
||||
Activity |
IC50 = 100000 nM
|
[5] | |||
Compound Name |
(2S)-1-[5-(2-Fluoro-1,1'-biphenyl-4-ylmethoxy)pentyl]-2beta-(hydroxymethyl)piperidine-3beta,4alpha,5beta-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354637; SCHEMBL17132922; BDBM50028257
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[(2-phenylphenyl)methoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354630; SCHEMBL17133012; BDBM50028250
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-1-[4,4-Difluoro-5-[(4-phenylphenyl)methoxy]pentyl]-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354633; SCHEMBL19224270; BDBM50028253
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
Valienamine
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
(1S,2S,3R,6S)-6-amino-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol; 6-AMINO-4-HYDROXYMETHYL-CYCLOHEX-4-ENE-1,2,3-TRIOL; SCHEMBL3960550; CHEMBL1230806; CTK4H9548; DTXSID80191622; ZINC5413017; BDBM50366472; AKOS006294151; DB02120; 148292-EP2284152A2; 148292-EP2289893A1; 231V866; A824072; Q427997; W-202570; (1S,2S,3R,6S)-6-azanyl-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
Click to Show/Hide
|
||||
Activity |
IC50 = 100000 nM
|
[1] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[[4-phenyl-3-(trifluoromethyl)phenyl]methoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354635; SCHEMBL17133008; BDBM50028255
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-[5-[[4-phenyl-2-(trifluoromethyl)phenyl]methoxy]pentyl]piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL3354634; SCHEMBL17132966; BDBM50028254
Click to Show/Hide
|
||||
Activity |
IC50 ~ 100000 nM
|
[7] | |||
Compound Name |
(5S,8R,9S,10S,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one;(8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1744444
Click to Show/Hide
|
||||
Activity |
IC50 = 100000 nM
|
[1] | |||
Compound Name |
(5Z)-3-[(E)-2-[(1S,2S,4As,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethylspiro[3,4,4a,6,7,8-hexahydro-1H-naphthalene-2,2'-oxirane]-1-yl]ethenyl]-5-[(E)-3-phenylprop-2-enylidene]furan-2-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL205969; BDBM50183251
Click to Show/Hide
|
||||
Activity |
IC50 = 101000 nM
|
[4] | |||
Compound Name |
(S)-3-(2-((4Ar,6aS,7R,10aS,10bR)-6a,10b-dimethyl-8-methylene-3-phenyl-decahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)-4-hydroxy-dihydrofuran-2(3H)-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL380336; SCHEMBL19698680; BDBM50183255; J3.517.186J
Click to Show/Hide
|
||||
Activity |
IC50 = 101000 nM
|
[4] | |||
Compound Name |
5-Butylidene-3-(2-((1R,4aS,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-decahydronaphthalen-1-yl)vinyl)furan-2(5H)-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL206309; BDBM50183254
Click to Show/Hide
|
||||
Activity |
IC50 = 110000 nM
|
[4] | |||
Compound Name |
(2R,3R,5R,6R)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
alpha-Homomannojirimycin; CHEMBL2114210; Homomannojirimycin; .alpha.-Homomannojirimycin; SCHEMBL1479404; BDBM50408431; 2,6-imino-2,6-dideoxy-d-glycero-d-talo-heptitol
Click to Show/Hide
|
||||
Activity |
IC50 = 110000 nM
|
[8] | |||
Compound Name |
Validamine
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
(1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol; (+)-validamine; 1-Amino-1,5,6-trideoxy-5-(hydroxymethyl)-D-chiro-inositol; CHEMBL1628264; 1D-1-amino-1,5,6-trideoxy-5-(hydroxymethyl)-chiro-inositol; (1R,2S,3S,4S)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol; 4-Amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol; PT141 Acetate(Bremelanotide); SCHEMBL5793335; CTK4G9281; DTXSID60954439; ZINC5850992; 5019AF; BDBM50367332; AKOS006284984; AC-4499; SC-94860; 780V328; Q27113564; D-chiro-Inositol, 1-amino-1,5,6-trideoxy-5-(hydroxymethyl)-
Click to Show/Hide
|
||||
Activity |
IC50 = 110000 nM
|
[5] | |||
Compound Name |
(5Z)-3-[(E)-2-[(1S,2S,4As,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethylspiro[3,4,4a,6,7,8-hexahydro-1H-naphthalene-2,2'-oxirane]-1-yl]ethenyl]-5-[(4-methoxyphenyl)methylidene]furan-2-one
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL205155; BDBM50183256
Click to Show/Hide
|
||||
Activity |
IC50 = 120000 nM
|
[4] | |||
Click to Show/Hide the Information of All Poor Binders |
Non Binders of This Target (in total, 8 non binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
N-[5-(Adamantan-1-yl-methoxy)-pentyl]-L-ido-1-deoxynojirimycin
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1086996; SCHEMBL17132912; BDBM50312527; ZINC49054534; (2S)-1-[5-(1-Adamantylmethoxy)pentyl]-2beta-(hydroxymethyl)piperidine-3beta,4alpha,5beta-triol
Click to Show/Hide
|
||||
Activity |
IC50 > 500000 nM
|
[7] | |||
Compound Name |
3,4-Pyrrolidinediol, 2-(hydroxymethyl)-1-methyl-, (2R,3R,4R)-
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
MeDAB; CHEMBL80148; (2R,3R,4R)-2-(hydroxymethyl)-1-methylpyrrolidine-3,4-diol; N-Methyl-1,4-dideoxy-1,4-imino-D-arabinitol; 3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-, (2R,3R,4R)-; SCHEMBL6135276; CTK4B0520; DTXSID70151972; BDBM50031480; 1,4-(Methylimino)-1,4-dideoxy-D-arabinitol; (2R,3R,4R)-2-(hydroxymethyl)-1-methyl-pyrrolidine-3,4-diol; (2R,3R,4R)-2-Hydroxymethyl-1-methyl-pyrrolidine-3,4-diol
Click to Show/Hide
|
||||
Activity |
IC50 = 500000 nM
|
[9] | |||
Compound Name |
Precose
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
acarbose; Glucobay; Bay-g-5421; Prandase; Beta-Acarbose; BAY-g 5421; CHEMBL1566; Bay g 5421; DSSTox_CID_26034; DSSTox_RID_81300; DSSTox_GSID_46034; Glucor; Arcabose; Ascarbose; NCGC00159353-02; Acarbose, >=95%; SCHEMBL16848; GTPL6791; DTXSID8046034; BCPP000442; HMS3269L19; HMS3413P19; HMS3677P19; HMS3713B18; Tox21_111597; BDBM50333465; s1271; ZINC85537042; AKOS024457233; Tox21_111597_1; BCP9000224; CCG-220568; NCGC00160515-02; AB01274765-01; AB01274765_02; Q338005; BRD-K44276885-001-01-7; BRD-K44276885-001-07-4; Acarbose, European Pharmacopoeia (EP) Reference Standard; UNII-T58MSI464G component XUFXOAAUWZOOIT-SXARVLRPSA-N; Acarbose, United States Pharmacopeia (USP) Reference Standard; Acarbose for identification, European Pharmacopoeia (EP) Reference Standard; Acarbose, Pharmaceutical Secondary Standard; Certified Reference Material
Click to Show/Hide
|
||||
Activity |
IC50 = 906000 nM
|
[2] | |||
Compound Name |
N-Butyl-L-ido-1-deoxynojirimycin
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1076754; SCHEMBL20576705; ZINC3957104; BDBM50312526; (2S,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
||||
Activity |
IC50 > 1000000 nM
|
[10] | |||
Compound Name |
(2S,3S,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1088291; N-Butyl-L-altro-1-deoxynojirimycin; BDBM50312530; ZINC11681341; 1-Butyl-2beta-(hydroxymethyl)piperidine-3alpha,4alpha,5beta-triol
Click to Show/Hide
|
||||
Activity |
IC50 > 1000000 nM
|
[10] | |||
Compound Name |
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3R,4R,5S)-
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
1-deoxy-L-idonojirimycin; CHEMBL175901; L-ido-1-Deoxynojirimycin; SCHEMBL4330678; 1,5-dideoxy-1,5-imino-l-iditol; ZINC3870514; BDBM50312525; (2S,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; (2S,3R,4R,5S)-2-Hydroxymethyl-piperidine-3,4,5-triol
Click to Show/Hide
|
||||
Activity |
IC50 > 1000000 nM
|
[10] | |||
Compound Name |
N-[5-(Adamantan-1-yl-methoxy)-pentyl]-L-altro-1-deoxynojirimycin
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL1088292; BDBM50312531
Click to Show/Hide
|
||||
Activity |
IC50 > 1000000 nM
|
[10] | |||
Compound Name |
3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3S,4R,5S)-
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL179409; 1-Deoxy-L-altrostatin; L-altro-1-Deoxynojirimycin; SCHEMBL4619759; BDBM50163445; ZINC13612564; (2s,3s,4r,5s)-2-(hydroxymethyl)piperidin-3,4,5-triol; (2S,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; (2S,3S,4R,5S)-2-Hydroxymethyl-piperidine-3,4,5-triol
Click to Show/Hide
|
||||
Activity |
IC50 > 1000000 nM
|
[10] | |||
Click to Show/Hide the Information of All Non Binders |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Synthesis of potent beta-D-glucocerebrosidase inhibitors: N-alkyl-beta-valienamines. Bioorg Med Chem Lett. 1996 Apr 23;6(8):929-32. | ||||
REF 2 | Synthesis of novel inhibitors of alpha-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. Eur J Med Chem. 2015 Mar 6;92:387-400. | ||||
REF 3 | Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors. Bioorg Med Chem. 2007 Jun 15;15(12):4247-55. | ||||
REF 4 | Studies on the novel alpha-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues. Bioorg Med Chem Lett. 2006 May 15;16(10):2710-3. | ||||
REF 5 | Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. J Med Chem. 1986 Jun;29(6):1038-46. | ||||
REF 6 | Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membe... Bioorg Med Chem. 2010 Nov 15;18(22):7794-8. | ||||
REF 7 | Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors. J Med Chem. 2014 Nov 13;57(21):9096-104. | ||||
REF 8 | Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. J Med Chem. 1998 Jul 2;41(14):2565-71. | ||||
REF 9 | N-alkylated nitrogen-in-the-ring sugars: conformational basis of inhibition of glycosidases and HIV-1 replication. J Med Chem. 1995 Jun 23;38(13):2349-56. | ||||
REF 10 | Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation. J Med Chem. 2010 Jan 28;53(2):689-98. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.